Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorNearchou, Ines P.
dc.contributor.authorGwyther, Bethany M.
dc.contributor.authorGeorgiakakis, Elena C. T.
dc.contributor.authorGavriel, Christos
dc.contributor.authorLillard, Kate
dc.contributor.authorKajiwara, Yoshiki
dc.contributor.authorUeno, Hideki
dc.contributor.authorHarrison, David James
dc.contributor.authorCaie, Peter David
dc.date.accessioned2020-05-21T10:30:02Z
dc.date.available2020-05-21T10:30:02Z
dc.date.issued2020-05-15
dc.identifier.citationNearchou , I P , Gwyther , B M , Georgiakakis , E C T , Gavriel , C , Lillard , K , Kajiwara , Y , Ueno , H , Harrison , D J & Caie , P D 2020 , ' Spatial immune profiling of the colorectal tumor microenvironment predicts good outcome in stage II patients ' , npj Digital Medicine , vol. 3 , 71 . https://doi.org/10.1038/s41746-020-0275-xen
dc.identifier.issn2398-6352
dc.identifier.otherPURE: 267524839
dc.identifier.otherPURE UUID: 78af5f1c-f00e-4c5a-a4f3-d892a12e9b67
dc.identifier.otherORCID: /0000-0001-9041-9988/work/74510266
dc.identifier.otherORCID: /0000-0002-0031-9850/work/74510315
dc.identifier.otherORCID: /0000-0002-1863-5413/work/75610531
dc.identifier.otherWOS: 000536096000001
dc.identifier.otherScopus: 85088068233
dc.identifier.urihttp://hdl.handle.net/10023/19977
dc.descriptionThis study was funded by Medical Research Scotland and Indica Labs, Inc., who also provided in-kind resource.en
dc.description.abstractCellular subpopulations within the colorectal tumor microenvironment (TME) include CD3+ and CD8+ lymphocytes, CD68+ and CD163+ macrophages, and tumor buds (TBs), all of which have known prognostic significance in stage II colorectal cancer. However, the prognostic relevance of their spatial interactions remains unknown. Here, by applying automated image analysis and machine learning approaches, we evaluate the prognostic significance of these cellular subpopulations and their spatial interactions. Resultant data, from a training cohort retrospectively collated from Edinburgh, UK hospitals (n = 113), were used to create a combinatorial prognostic model, which identified a subpopulation of patients who exhibit 100% survival over a 5-year follow-up period. The combinatorial model integrated lymphocytic infiltration, the number of lymphocytes within 50-μm proximity to TBs, and the CD68+/CD163+ macrophage ratio. This finding was confirmed on an independent validation cohort, which included patients treated in Japan and Scotland (n = 117). This work shows that by analyzing multiple cellular subpopulations from the complex TME, it is possible to identify patients for whom surgical resection alone may be curative.
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofnpj Digital Medicineen
dc.rightsCopyright © The Author(s) 2020. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.en
dc.subjectColorectal canceren
dc.subjectImage analysisen
dc.subjectTumor microenvironmenten
dc.subjectPrognosisen
dc.subjectDigital pathologyen
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectRB Pathologyen
dc.subjectQA76 Computer softwareen
dc.subjectNDASen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subject.lccRC0254en
dc.subject.lccRBen
dc.subject.lccQA76en
dc.titleSpatial immune profiling of the colorectal tumor microenvironment predicts good outcome in stage II patientsen
dc.typeJournal articleen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews. Cellular Medicine Divisionen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.contributor.institutionUniversity of St Andrews. Sir James Mackenzie Institute for Early Diagnosisen
dc.contributor.institutionUniversity of St Andrews. Centre for Biophotonicsen
dc.identifier.doihttps://doi.org/10.1038/s41746-020-0275-x
dc.description.statusPeer revieweden


This item appears in the following Collection(s)

Show simple item record